Skip to main content
. 2014 Mar 19;15:42. doi: 10.1186/1471-2202-15-42

Table 2.

Sample characteristics

Variables Mean (SD) or percentage Median (Q25, Q75)
Age (years)
47.28 (11.51)
48 (39, 56)
Marital status (married/unmarried)
15/47 (yes: 31.91%)
---
Weight (kg)
65.69 (11.59)
65 (56.5, 75)
Height (m)
1.62 (0.17)
1.6 (1.56, 1.64)
Education (years)
13.19 (4.20)
13 (11, 16)
Trait-anxiety
23.89 (6.90)
22.5 (19, 29)
State-anxiety
28.22 (7.80)
26 (22, 34)
Beck depression inventory
15.02 (9.27)
13.5 (9, 19)
Brazilian Portuguese Catastrophizing Scale (B-PCS)
29.36 (12.59)
33 (20, 39)
Pain lasting longer than one year (yes/no)
40/48 (yes: 83.33%)
---
Total score on the Profile of Chronic Pain: Screen for Brazilian population (B-PCP:S)
59.70 (15.75)
62 (49, 71)
Score on B-PCP:S domains
 
 
 Intensity
24.6 (3.3)
25 (23, 27)
 Interference in daily activity
21.98 (9.35)
24 (18, 30)
 Emotional burden
13.11 (6.24)
13 (9, 18)
Number of days analgesics were used per week in the last three months (< 4 times/≥ 4 times)a
22/47 (< 4 times: 46.81%)
---
Smoking (yes/no)
26/47 (yes: 55.32%)
---
Alcohol consumption (yes/no)
26/47 (yes: 55.32%)
---
Presence of other chronic diseases before appearance of pain (yes/no)b
21/47 (yes: 44.68%)
---
Diagnosis of psychiatric disorders (yes/no)
18/47 (yes: 38.30%)
---
Active use of central nervous system medication (yes/no)c 4/47 (yes: 8.51%) ---

a The same patient may have used more than one medication.

b Chronic diseases other than pain: hypertension (n = 12); ischemic heart disease (n = 1); heart attack (n = 1); diabetes mellitus (n = 5); thyroid diseases (n = 2); other chronic diseases listed (n = 0).

c Central nervous medication: tricyclic antidepressant (n = 2); topiromate (n = 1) tylex (n = 1).

Data presented as Mean (SD) or median (interquartile) or proportion (n = 47).